DK0817859T3 - Rekombinante DNA vektorer til Genterapi - Google Patents

Rekombinante DNA vektorer til Genterapi

Info

Publication number
DK0817859T3
DK0817859T3 DK96907399T DK96907399T DK0817859T3 DK 0817859 T3 DK0817859 T3 DK 0817859T3 DK 96907399 T DK96907399 T DK 96907399T DK 96907399 T DK96907399 T DK 96907399T DK 0817859 T3 DK0817859 T3 DK 0817859T3
Authority
DK
Denmark
Prior art keywords
gene therapy
recombinant dna
dna vectors
novel
cells
Prior art date
Application number
DK96907399T
Other languages
English (en)
Inventor
Walter H Guenzburg
Brian Salmons
Original Assignee
Austrian Nordic Biotherapeutic
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Austrian Nordic Biotherapeutic, Gsf Forschungszentrum Umwelt filed Critical Austrian Nordic Biotherapeutic
Application granted granted Critical
Publication of DK0817859T3 publication Critical patent/DK0817859T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96907399T 1995-03-09 1996-03-08 Rekombinante DNA vektorer til Genterapi DK0817859T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK24495 1995-03-09
PCT/EP1996/001002 WO1996028564A1 (en) 1995-03-09 1996-03-08 Novel recombinant dna vectors for gene therapy

Publications (1)

Publication Number Publication Date
DK0817859T3 true DK0817859T3 (da) 2002-04-29

Family

ID=8091367

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96907399T DK0817859T3 (da) 1995-03-09 1996-03-08 Rekombinante DNA vektorer til Genterapi

Country Status (9)

Country Link
US (1) US6730511B1 (da)
EP (2) EP0817859B1 (da)
JP (1) JPH11508441A (da)
AT (1) ATE212061T1 (da)
AU (1) AU5104096A (da)
DE (1) DE69618579T2 (da)
DK (1) DK0817859T3 (da)
ES (1) ES2171657T3 (da)
WO (1) WO1996028564A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2199585C2 (ru) * 1994-09-02 2003-02-27 ГСФ-Форшунгсцентрум фюр Умвельт унд Гезундхайт ГмбХ Ретровирусная векторная конструкция, подвергающаяся промоторной конверсии, способ введения гомологичных или гетерологичных нуклеотидных последовательностей в человеческие или животные клетки in vitro и/или in vivo, рекомбинантная ретровирусная частица, фармацевтическая композиция для генной терапии
DE69627644T2 (de) 1995-03-09 2004-02-19 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Vektoren, die therapeutische gene fuer antimikrobielle peptide enthalten, zur verwendung in der gentherapie
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
DE102009024862A1 (de) 2009-06-09 2010-12-16 Uwe Michael Schlitt Dosiervorrichtung für flüssige Medien

Also Published As

Publication number Publication date
ATE212061T1 (de) 2002-02-15
WO1996028564A1 (en) 1996-09-19
DE69618579D1 (de) 2002-02-21
DE69618579T2 (de) 2002-10-02
ES2171657T3 (es) 2002-09-16
US6730511B1 (en) 2004-05-04
AU5104096A (en) 1996-10-02
EP0817859A1 (en) 1998-01-14
EP1162273A1 (en) 2001-12-12
JPH11508441A (ja) 1999-07-27
EP0817859B1 (en) 2002-01-16

Similar Documents

Publication Publication Date Title
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
DE69936784D1 (de) Behandlung von gebärmutterhalskrebs
ES2172502T3 (es) Receptores tipo ii de interleucina 1.
DE69638196D1 (de) Rekombinantes sendai-virus
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
NL300008I2 (nl) Tumornecrosis factor-alfa en -bet-receptors.
NO961115D0 (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
ATE315087T1 (de) Neuartige auf p53 ansprechende gene
ATE549347T1 (de) Gene von säugetiere, und damit verbundene reagentien, methoden
ATE141946T1 (de) Hiv-2-virusvarianten
NL300271I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
HUP9801608A2 (hu) A 11. típusú humán papillomavírusból származó L1-fehérjét kódoló szintetikus HPV6/11-L1-hibrid-DNS
DK22389D0 (da) Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma
NO975286L (no) Promotere for genekspresjon
EP0613945A3 (en) Tumor suppressor gene Merlin and its uses.
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof
DK0843731T3 (da) Adenovirusvektorer til genterapi
ES2171657T3 (es) Vector de dna recombinante para terapia genica.
DE69839582D1 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
DE69638120D1 (de) Konditionell replizierende virale Vektoren und ihre Verwendung
ATE238427T1 (de) Vektoren, die therapeutische gene fuer antimikrobielle peptide enthalten, zur verwendung in der gentherapie
DK498387D0 (da) Virus-dna-sekvens
DE3853693D1 (de) DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
WO1992014818A3 (en) Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
DE69925927D1 (de) Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung